TCA
Trifecta Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.83M | Buy |
15,340
+802
| +6% | +$357K | 1.14% | 34 |
|
|
2025
Q1 | $7.05M | Buy |
14,538
+573
| +4% | +$278K | 1.48% | 20 |
|
|
2024
Q4 | $5.62M | Buy |
13,965
+430
| +3% | +$173K | 1.11% | 29 |
|
|
2024
Q3 | $6.29M | Buy |
13,535
+219
| +2% | +$102K | 1.32% | 22 |
|
|
2024
Q2 | $6.24M | Buy |
13,316
+955
| +8% | +$448K | 1.38% | 17 |
|
|
2024
Q1 | $5.17M | Buy |
12,361
+526
| +4% | +$220K | 1.26% | 23 |
|
|
2023
Q4 | $4.82M | Buy |
11,835
+350
| +3% | +$142K | 1.33% | 22 |
|
|
2023
Q3 | $3.99M | Buy |
11,485
+685
| +6% | +$238K | 1.28% | 22 |
|
|
2023
Q2 | $3.8M | Buy |
10,800
+990
| +10% | +$348K | 1.22% | 22 |
|
|
2023
Q1 | $3.09M | Buy |
9,810
+5,260
| +116% | +$1.66M | 1.09% | 26 |
|
|
2022
Q4 | $1.31M | Buy |
+4,550
| New | +$1.31M | 0.52% | 51 |
|